Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2008-09-03 08:09 |
FDA authorizes Investigational New Drug application for recombinant human C1 in…
|
English | 73.4 KB | ||
| 2008-09-03 08:09 |
FDA authorizes Investigational New Drug application for recombinant human C1 in…
|
English | 77.4 KB | ||
| 2008-08-05 08:07 |
Pharming announces first Half 2008 Results
|
English | 116.6 KB | ||
| 2008-08-04 12:10 |
Pharming included in Amsterdam Midkap Index on NYSE Euronext
|
English | 68.7 KB | ||
| 2008-08-04 12:10 |
Pharming included in Amsterdam Midkap Index on NYSE Euronext
|
English | 68.2 KB | ||
| 2008-07-15 07:55 |
DNAGE TO PARTICIPATE IN EUROPEAN STUDY ON BIOMARKERS OF AGEING
|
English | 69.5 KB | ||
| 2008-07-15 07:55 |
DNAGE TO PARTICIPATE IN EUROPEAN STUDY ON BIOMARKERS OF AGEING
|
English | 70.6 KB | ||
| 2008-07-11 08:34 |
Pharming announces positive results from Rhucin® open-label clinical studies
|
English | 77.4 KB | ||
| 2008-06-25 14:35 |
PHARMING ACQUIRES LICENSES TO KEY FIBRINOGEN PATENTS
|
English | 77.1 KB | ||
| 2008-06-16 17:14 |
PHARMING ANNOUNCES POSITIVE RESULTS FROM NORTH AMERICAN RANDOMIZED TRIAL WITH R…
|
English | 76.4 KB | ||
| 2008-04-23 12:20 |
PHARMING STARTS CLINICAL PROGRAM IN AGEING DISEASES
|
English | 17.0 KB | ||
| 2008-04-18 08:08 |
Pharming announces first quarter 2008 results
|
English | 87.5 KB | ||
| 2008-04-16 14:02 |
Pharming provides update on business strategy at shareholders meeting
|
English | 147.4 KB | ||
| 2008-03-04 08:21 |
Pharming's Annual General Meeting of Shareholders to be held in Leiden on 16 Ap…
|
English | 67.5 KB | ||
| 2008-03-04 08:21 |
Pharming's Annual General Meeting of Shareholders to be held in Leiden on 16 Ap…
|
English | 70.5 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
